title: Coxsackie B1 infection associated with ventriculitis.
authors.affiliation: Department of Pediatrics, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA.
authors.forename: Lia Simpson
authors.initials: LS
authors.lastname: Erickson
authors.forename: Gretchen
authors.initials: G
authors.lastname: Hoyle
authors.forename: Jon
authors.initials: J
authors.lastname: Abramson
authors.forename: Louise C
authors.initials: LC
authors.lastname: Hester
authors.forename: Avinash
authors.initials: A
authors.lastname: Shetty
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D002552:Cerebral Ventricles / Q000503:physiopathology / Q000821:virology*; D003384:Coxsackievirus Infections / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D004569:Electroencephalography; D018792:Encephalitis, Viral / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D029822:Enterovirus B, Human / Q000187:drug effects / Q000302:isolation & purification*; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D008279:Magnetic Resonance Imaging; D008297:Male; D008587:Meningitis, Viral / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D018570:Risk Assessment; D012720:Severity of Illness Index
chemical_list: D000998:Antiviral Agents